← All investors
Novartis Venture Fund
41 portfolio companies · 2 on the map · $536.8M raised · 2 cities
Portfolio map
2 Novartis Venture Fund portfolio companies on the map.
Portfolio companies
Akebia Therapeutics
Cambridge
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Biotechnology Research$442.5MEst. 2007Amphora Discovery
Durham
Amphora Discovery Corporation operates as a biotechnology company.
Biotechnology Research$94.3MEst. 2001
More portfolio companies
39 more Novartis Venture Fund investments we track beyond the map.
Sidewinder TherapeuticsSan Diego · Series B
YourBio HealthMedford · Series B
Mediar TherapeuticsBoston · Series A
CatalYmPlanegg · Series D
Fore BiotherapeuticsPhiladelphia · Series D
EpiBiologicsSan Mateo · Series B
NRG TherapeuticsCambridge · Series B
Atalanta TherapeuticsBoston · Series B
TScan TherapeuticsWaltham · Series C
Protego BiopharmaSan Diego · Series B
Ribon TherapeuticsCambridge · Series C
AnaveonBottmingen · Series B
Averna TherapeuticsBoston · Series A
AstronauTxReading · Series A
Immunitas TherapeuticsCambridge · Series B
AltimmuneGaithersburg · Post-IPO Equity
Tagworks PharmaceuticalsNijmegen · Series A
Galera TherapeuticsMalvern · Series C
Exo TherapeuticsCambridge · Series B
ONL TherapeuticsAnn Arbor · Series D
ImmPACT BioCamarillo · Series B
Bionano GenomicsSan Diego · Series D
FORMA TherapeuticsWatertown · Series C
NovImmunePlan-les-ouates · Venture
AnokionEcublens · Series B
AkouosBoston · Series B
CavionCharlottesville · Series A
Ra PharmaceuticalsCambridge · Series B
Nabriva TherapeuticsVienna · Series B
Proteostasis TherapeuticsCambridge · Series B
Arctos MedicalBern · Seed
Thesan PharmaceuticalsCarlsbad · Series B
MerLion PharmaSingapore · Series A
NuraSeattle · Series A
EraGen BiosciencesMadison · Series A
VisiogenIrvine · Series E
AGY TherapeuticsSan Francisco · Series C
Cylene PharmaceuticalsSan Diego · Series D
Cequent PharmaceuticalsCambridge · Series A
Portfolio map
2 Novartis Venture Fund portfolio companies on the map.